RLReal W Lapointe

Real W Lapointe

*This is an algorithmically generated author record based on publicly available information.

Real W Lapointe has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Otmane Nafidi

    Department of Surgery, Centre hospitalier de l'Université de Montréal (CHUM)-Hôpital St-Luc, Montreal, Quebec, Canada

    2 shared publications
  • André Roy

    Departments of Surgery, Montreal, Quebec, Canada

    1 shared publication
  • Bernard E Willems

    Medicine, Centre Hospitalier de l’Université de Montréal (CHUM), Hôpital St Luc, Montréal, QC, Canada

    1 shared publication
  • Delphine Désy

    Pathology, Centre hospitalier de l'Université de Montréal (CHUM) – Hôpital St-Luc, Montreal, Quebec, Canada

    1 shared publication
  • Franck Vandenbroucke-Menu

    Department of Hepatobiliary-Pancreatic Surgery and Transplantation, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

    1 shared publication
  • Jean Côté

    Pathology, Centre hospitalier de l'Université de Montréal (CHUM) – Hôpital St-Luc, Montreal, Quebec, Canada

    1 shared publication

Latest Publications

  • Open Access

    Hypertrophy of the non-embolized liver after chemotherapy

    by Otmane Nafidi, Delphine Désy, Richard Létourneau, Jean Côté, Marylène Plasse, Franck Vandenbroucke, André Roy, Michel Dagenais, Réal W. Lapointe


  • Reuse of liver graft from a brain dead recipient

    by Otmane Nafidi, Richard Letourneau, Bernard E Willems, Real W Lapointe

    Brain death in fulminant hepatic failure (FHF) is a rare occurrence after successful orthotopic liver transplantation (OLT). Reuse of the liver graft may be considered. We report a successful OLT using such an organ in a 62-yr-old man with hematochromatosis-related cirrhosis and hepatocellular carcinoma. Liver donor was 56-yr-old man with normal liver function tests. First recipient was a 26-yr-old woman with an acetaminophen-induced FHF. Before OLT, she developed progressive coma without obvious cerebral edema on the cerebral CT-scan. The transplantation proceeded as planned and was uneventful. However, patient exhibited bilateral non-reactive mydriasis during postoperative hours and was declared brain dead. Transplanted liver was functioning adequately. Its reuse was discussed with her family and the second recipient. After informed consent, the transplanted liver and heart were harvested. First and second liver cold ischemia times were 10 h and 75 min, respectively. Second recipient recovered uneventful and discharged 23 d after OLT. Liver function is still normal 30 months after OLT without rejection or hepatocellular carcinoma recurrence. Even after OLT, brain death remains possible in FHF. In absence of contraindications, reuse of transplanted liver allows for a rational use of already rare liver grafts.